Munich Reinsurance Co Stock Corp in Munich Sells 57,527 Shares of Oracle Corporation $ORCL

Key Points

• Munich Reinsurance Co Stock Corp in Munich sold 57,527 shares of Oracle in Q4, cutting its stake by 52.8% to 51,493 shares valued at about $10.16 million after the transaction.
• Two insiders sold shares: EVP Stuart Levey sold 15,000 shares at an average $176.19 under a Rule 10b5‑1 plan, and CEO Clayton Magouyrk sold 10,000 shares at $155.23, modestly reducing their holdings.
• Analyst and market backdrop: Oracle has a "Moderate Buy" consensus with a $259.56 average target amid bullish AI/data‑center narratives and concerns over spending, and the stock was trading down about 1.6% (opening at $173.51) on the latest session.

Munich Reinsurance Co Stock Corp in Munich lowered its holdings in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 52.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 51,493 shares of the enterprise software provider's stock after selling 57,527 shares during the period. Munich Reinsurance Co Stock Corp in Munich's holdings in Oracle were worth $10,155,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in ORCL. Jennison Associates LLC grew its holdings in shares of Oracle by 2,062.4% during the 3rd quarter. Jennison Associates LLC now owns 9,227,252 shares of the enterprise software provider's stock valued at $2,595,072,000 after purchasing an additional 8,800,546 shares during the last quarter. Vanguard Group Inc. boosted its position in Oracle by 2.8% during the 3rd quarter. Vanguard Group Inc. now owns 168,960,500 shares of the enterprise software provider's stock valued at $47,518,451,000 after buying an additional 4,681,626 shares during the period. American Century Companies Inc. boosted its position in Oracle by 333.7% during the 3rd quarter. American Century Companies Inc. now owns 5,238,006 shares of the enterprise software provider's stock valued at $1,473,137,000 after buying an additional 4,030,382 shares during the period. Amundi boosted its position in Oracle by 32.9% during the 3rd quarter. Amundi now owns 9,636,090 shares of the enterprise software provider's stock valued at $2,809,609,000 after buying an additional 2,385,556 shares during the period. Finally, SG Americas Securities LLC boosted its position in Oracle by 921.6% during the 4th quarter. SG Americas Securities LLC now owns 2,311,815 shares of the enterprise software provider's stock valued at $450,596,000 after buying an additional 2,085,514 shares during the period. Institutional investors own 42.44% of the company's stock.

Insider Transactions at Oracle

In related news, EVP Stuart Levey sold 15,000 shares of Oracle stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $176.19, for a total transaction of $2,642,850.00. Following the completion of the transaction, the executive vice president directly owned 3,429 shares of the company's stock, valued at $604,155.51. This trade represents a 81.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Clayton M. Magouyrk sold 10,000 shares of Oracle stock in a transaction dated Monday, February 9th. The shares were sold at an average price of $155.23, for a total transaction of $1,552,300.00. Following the transaction, the chief executive officer directly owned 134,030 shares of the company's stock, valued at approximately $20,805,476.90. This trade represents a 6.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 40.90% of the company's stock.

Analysts Set New Price Targets

ORCL has been the subject of several analyst reports. The Goldman Sachs Group raised shares of Oracle to a "strong-buy" rating in a research report on Monday, January 12th. Citigroup increased their price target on shares of Oracle from $310.00 to $320.00 and gave the company a "buy" rating in a research report on Thursday, March 12th. Cantor Fitzgerald reissued an "overweight" rating and set a $229.00 price target on shares of Oracle in a research report on Wednesday, March 11th. Piper Sandler dropped their price target on shares of Oracle from $240.00 to $210.00 and set an "overweight" rating for the company in a research report on Wednesday, March 11th. Finally, Stifel Nicolaus dropped their price target on shares of Oracle from $275.00 to $220.00 and set a "buy" rating for the company in a research report on Wednesday, March 11th. Four investment analysts have rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Oracle has an average rating of "Moderate Buy" and a consensus target price of $259.56.

More Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Wedbush initiated coverage with an Outperform rating and framed Oracle as a foundational AI infrastructure play, setting a $225 price target that signals substantial upside vs. current levels. Wedbush Crowns Oracle a Foundational AI Infrastructure Play With a $225 Price Target
• Positive Sentiment: Wedbush’s Dan Ives publicly said Wall Street is underestimating Oracle and suggested the stock could materially outperform, a bullish narrative that supports longer‑term expectations for AI backlog monetization. Oracle Stock Could Double, Ives Says
• Positive Sentiment: Oracle continues to expand AI and cloud partnerships (e.g., Google Cloud database agent, DENSO collaboration, and large financing plans for data‑center buildouts) that underpin its AI infrastructure thesis and potential multicloud revenue growth. Oracle And Google Cloud Link AI To Keep Enterprise Data On Oracle
• Neutral Sentiment: Several retail and advisory writeups are repeating bullish theses (safe stock / long‑term AI upside) that may support buy‑and‑hold demand but are unlikely to move price until revenue/capex visibility improves. Is Oracle Corporation (ORCL) A Good Stock To Buy Now?
• Neutral Sentiment: Market commentators highlight rotation into software names as a thematic tailwind for ORCL, but note the path is bumpy and dependent on broader risk sentiment. Follow the Flow: 3 Stocks Absorbing the Market's Biggest Rotation
• Negative Sentiment: Reports that Oracle cancelled a large Super Micro order (estimated $1.1B–$1.4B) triggered immediate selling and raised questions over timing/scale of Oracle’s server purchases and supply‑chain relationships. Oracle stock falls 3%: why this analyst still sees upside
• Negative Sentiment: Broader coverage warns Oracle’s aggressive AI data‑center spending is straining financing markets and investor patience, feeding concerns about execution risk and balance‑sheet strain. Oracle's Deluge of AI Debt Pushes Wall Street to the Limit
• Negative Sentiment: Morgan Stanley trimmed its price target and holds an Equal‑Weight stance, a reminder some sell‑side shops remain cautious and that not all analysts are aligned with the bullish backlog story. ORCL price target lowered by Morgan Stanley

Oracle Trading Down 1.6%

NYSE:ORCL opened at $173.51 on Friday. Oracle Corporation has a 12 month low of $134.57 and a 12 month high of $345.72. The stock has a market cap of $499.01 billion, a price-to-earnings ratio of 31.15, a P/E/G ratio of 1.68 and a beta of 1.60. The company has a 50-day moving average price of $154.21 and a 200-day moving average price of $193.27. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 3.66.

Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings results on Tuesday, March 10th. The enterprise software provider reported $1.79 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.08. Oracle had a net margin of 25.30% and a return on equity of 62.70%. The company had revenue of $17.19 billion during the quarter, compared to analysts' expectations of $16.91 billion. During the same period last year, the company posted $1.47 EPS. Oracle's revenue was up 21.7% on a year-over-year basis. Oracle has set its Q4 2026 guidance at 1.960-2.000 EPS. Equities analysts predict that Oracle Corporation will post 6.07 EPS for the current year.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, April 24th. Investors of record on Thursday, April 9th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend was Thursday, April 9th. Oracle's dividend payout ratio (DPR) is 35.91%.

Oracle Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle's product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.